Your browser doesn't support javascript.
loading
FBA reveals guanylate kinase as a potential target for antiviral therapies against SARS-CoV-2.
Renz, Alina; Widerspick, Lina; Dräger, Andreas.
Affiliation
  • Renz A; Computational Systems Biology of Infections and Antimicrobial-Resistant Pathogens, Institute for Bioinformatics and Medical Informatics (IBMI).
  • Widerspick L; Department of Computer Science, University of Tübingen, Tübingen 72076, Germany.
  • Dräger A; Computational Systems Biology of Infections and Antimicrobial-Resistant Pathogens, Institute for Bioinformatics and Medical Informatics (IBMI).
Bioinformatics ; 36(Suppl 2): i813-i821, 2020 12 30.
Article in En | MEDLINE | ID: mdl-33381848
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / COVID-19 Drug Treatment Limits: Humans Language: En Journal: Bioinformatics Journal subject: INFORMATICA MEDICA Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / COVID-19 Drug Treatment Limits: Humans Language: En Journal: Bioinformatics Journal subject: INFORMATICA MEDICA Year: 2020 Type: Article